{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Immuneering Corporation"},"Symbol":{"label":"Symbol","value":"IMRX"},"Address":{"label":"Address","value":"245 MAIN STREET,SECOND FLOOR, CAMBRIDGE, Massachusetts, 02142, United States"},"Phone":{"label":"Phone","value":"+1 617 500-8080"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies."},"CompanyUrl":{"label":"Company Url","value":"https://www.immuneering.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Benjamin J. Zeskind","title":"President, Chief Executive Officer & Director"},{"name":"Brett Hall","title":"Chief Scientific Officer"},{"name":"Scott Barrett","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}